Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2)
1_MALHD 6_ MEDFT 11_ FDGTK 16_ RLSVN 21_ YVKGI 26_ LQPTD 31_ TCDIW 36_ DKIWN 41_ FQAKP 46_ DDLLI 51_ STYPK 56_ AGTTW 61_ TQEIV 66_ ELIQN 71_ EGDVE 76_ KSKRA 81_ PTHQR 86_ FPFLE 91_ MKIPS 96_ LGSGL 101_ EQAHA 106_ MPSPR 111_ ILKTH 116_ LPFHL 121_ LPPSL 126_ LEKNC 131_ KIIYV 136_ ARNPK 141_ DNMVS 146_ YYHFQ 151_ RMNKA 156_ LPAPG 161_ TWEEY 166_ FETFL 171_ AGKVC 176_ WGSWH 181_ EHVKG 186_ WWEAK 191_ DKHRI 196_ LYLFY 201_ EDMKK 206_ NPKHE 211_ IQKLA 216_ EFIGK 221_ KLDDK 226_ VLDKI 231_ VHYTS 236_ FDVMK 241_ QNPMA 246_ NYSSI 251_ PAEIM 256_ DHSIS 261_ PFMRK 266_ GAVGD 271_ WKKHF 276_ TVAQN 281_ ERFDE 286_ DYKKK 291_ MTDTR 296_LTFHF
1: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of phenolic compounds. Can also sulfonate estrogenic compounds, however, the dietary flavonoids (phytoestrogen) and environmental estrogens, like bisphenol A are better substrates than 17beta-estradiol (E2) (PubMed:17425406, PubMed:26948952, PubMed:28222028, PubMed:9852044). Mediates the sulfation of doxorubicin and its analog epirubicin, two antitumor anthracyclines (PubMed:26948952)